Blood Test Using piRNAs Predicts Two-Year Survival in Older Adults

A Duke Health–University of Minnesota team analyzed blood from >1,200 adults aged 71+ using AI models that examined 187 clinical variables and 828 RNAs. Six piRNAs alone predicted two-year survival with up to 86 % accuracy, surpassing age, cholesterol, activity and 180 other indicators. The result was reproduced in an independent cohort.

SciTechDaily

Senior author Dr. Virginia Byers Kraus, professor of Medicine, Pathology and Orthopaedic Surgery at Duke University School of Medicine, led the effort with collaborators from Duke Health, the University of Minnesota and the North Carolina cohort. piRNAs, previously linked to development, regeneration and immune regulation in simple organisms, are now linked to human longevity, with lower blood levels correlating with longer survival.

SciTechDaily

Dr. Kraus noted that a few piRNAs offered stronger predictive power than traditional metrics, underscoring the utility of a simple blood test. The test could enable early risk stratification and guide interventions. She highlighted the possibility that piRNAs play a role in longevity while acknowledging that mechanisms remain unclear. Future work will test whether treatments or lifestyle changes can alter piRNA levels and will compare circulating versus tissue expression.

SciTechDaily

The causal link between piRNA abundance and lifespan is not established, and study population was confined to a North Carolina cohort of older adults. Broader validation across diverse demographics and study of piRNA function in blood versus tissues are needed before clinical adoption.

SciTechDaily

• “The combination of just a few piRNAs was the strongest predictor of two-year survival in older adults—stronger than age, lifestyle habits, or any other health measures we examined,” — Virginia Byers Kraus, M.D., Ph.D.

SciTechDaily

• “What surprised us most was that this powerful signal came from a simple blood test,” — Virginia Byers Kraus

SciTechDaily

• “We know very little about piRNAs in the blood, but what we’re seeing is that lower levels of certain specific ones is better,” — Virginia Byers Kraus

SciTechDaily

• “When these molecules are present in higher amounts, it may signal that something in the body is off-track. Understanding why could open new possibilities for therapies that promote healthy aging.” — Virginia Byers Kraus

SciTechDaily

• “These small RNAs are like micromanagers in the body, helping control many processes that affect health and aging,” — Virginia Byers Kraus

SciTechDaily

Planned studies will assess whether GLP-1-based drugs, lifestyle regimens or interventions can modify piRNA concentrations and will compare blood piRNA profiles with tissue levels to clarify relevance. Successful translation could yield a blood assay for short-term survival risk, informing personalized strategies to extend healthy lifespan.

SciTechDaily